Gene Name |
damage-specific DNA binding protein 2, 48kDa |
xeroderma pigmentosum, complementation group A |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Obesity-related traits ( 23251661)
- Thyroid cancer (Papillary, radiation-related) ( 20350937)
|
Protein-Protein Interactions |
15 interactors:
ABL1
CUL4A
CUL4B
DCLRE1C
DDB1
E2F1
HDAC1
HIST2H2AC
HIST2H3C
NTMT1
TOP1
USP24
USP40
XPA
XPC
|
20 interactors:
ATM
ATR
DDB1
DDB2
ERCC1
ERCC6
GPN1
GTF2E2
GTF2H1
HERC2
MSH2
MSH3
NDEL1
PRKDC
RASSF1
RPA1
RPA2
RPA4
TRIM27
XAB2
|
Entrez ID |
1643 |
7507 |
HPRD ID |
02886 |
02045 |
Ensembl ID |
ENSG00000134574
|
ENSG00000136936
|
Uniprot IDs |
Q92466
|
P23025
|
PDB IDs |
3EI4
3I7L
4E54
4E5Z
|
1D4U
1XPA
2JNW
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
adherens
bioassays
bladder
carcinogenic
carcinogens
chemicals
consistently
construct
discriminate
evaluating
foundation
gadd45a
genotoxic
genotoxicity
globaltest
hepg2
implemented
industry
investigating
junction
microarrays
pam
peroxisome
perturbation
pharmaceutical
rrm2b
set
sets
validate
|
|
Tagcloud (Difference) ? |
adherens
bioassays
bladder
carcinogenic
carcinogens
chemicals
consistently
construct
discriminate
evaluating
foundation
gadd45a
genotoxic
genotoxicity
globaltest
hepg2
implemented
industry
investigating
junction
microarrays
pam
peroxisome
perturbation
pharmaceutical
rrm2b
set
sets
validate
|
|
Tagcloud (Intersection) ? |
|